v3.22.2.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
$ in Thousands
CAD ($)
shares
Edibles and Infusions Corporation
CAD ($)
shares
Laurentian
CAD ($)
shares
Restricted share units
CAD ($)
shares
PSUs
CAD ($)
PSUs
shares
PSUs
Share
SHARE CAPITAL
CAD ($)
SHARE CAPITAL
Edibles and Infusions Corporation
CAD ($)
SHARE CAPITAL
Laurentian
CAD ($)
SHARE CAPITAL
Restricted share units
CAD ($)
SHARE CAPITAL
PSUs
CAD ($)
EQUITY RESERVES
CAD ($)
EQUITY RESERVES
Restricted share units
CAD ($)
EQUITY RESERVES
PSUs
CAD ($)
ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME
CAD ($)
ACCUMULATED DEFICIT
CAD ($)
Number of shares outstanding at beginning of period (in shares) at Aug. 31, 2020 | shares 194,511,061                                
Equity at beginning of period at Aug. 31, 2020 $ 299,527             $ 420,673         $ 23,744     $ 50 $ (144,940)
Unit financing, net of issue costs (in shares) | shares 37,375,000                                
Unit financing, net of issue costs $ 52,747             52,747                  
Private placement, net of issue costs (in shares) | shares 58,336,392                                
Private placement, net of issue costs $ 217,297             217,297                  
Shares issued related to business combination, net of issue costs (in shares) | shares   5,045,873                              
Shares issued related to business combination, net of issue costs 21,935             21,935                  
Share-based compensation $ 3,612                       3,612        
Exercise of stock options (in shares) | shares 1,691,498                                
Exercise of stock options $ 4,027             6,268         (2,241)        
Exercised of restricted share units or performance share units (in shares)       80,491   1,858 1,858,000                    
Exercise of restricted share units or performance share units       $ 0 $ 0           $ 382 $ 9   $ (382) $ (9)    
Exercise of warrants (in shares) | shares 1,743,850                                
Exercise of warrants $ 11,492             11,492                  
Foreign currency translation gain (loss), net of tax (128)                             (128)  
Net loss $ (130,704)                               (130,704)
Number of shares outstanding at end of period (in shares) at Aug. 31, 2021 | shares 298,786,023                                
Equity at end of period at Aug. 31, 2021 $ 479,805             730,803         24,724     (78) (275,644)
Shares issued related to business combination, net of issue costs (in shares) | shares   1,039,192 10,896,442                            
Shares issued related to business combination, net of issue costs   $ 3,488 $ 27,513           $ 3,488 $ 27,513              
Share-based compensation $ 5,127                       5,127        
Exercise of stock options (in shares) | shares 100,799                                
Exercise of stock options $ 74             127         (53)        
Exercised of restricted share units or performance share units (in shares)       259,000   74,331 74,331                    
Exercise of restricted share units or performance share units       $ 0 $ 0           $ 1,239 $ 221   $ (1,239) $ (221)    
Exercise of warrants (in shares) | shares 0                                
Foreign currency translation gain (loss), net of tax $ 0                                
Exercise of top-up rights, net of issue costs (in shares) | shares 2,659,716                                
Exercise of top-up rights, net of issue costs $ 6,334             6,334                  
Net loss $ (14,283)                               (14,283)
Number of shares outstanding at end of period (in shares) at Aug. 31, 2022 | shares 313,815,503                                
Equity at end of period at Aug. 31, 2022 $ 508,058             $ 769,725         $ 28,338     $ (78) $ (289,927)